Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WM-115 | Vemurafenib | Defactinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 3017 | 261 | 0.6588 | 0.6656 | 0.0865 | 0.0837 |
WM-115 | Vemurafenib | (+)-JQ1 | 3.160 | 0.000 | uM | 72 | hr | 2 | 2188 | 416 | 0.5437 | 0.4990 | 0.1901 | 0.1975 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 22342 | 1082 | 1.0188 | 1.0000 | 0.0484 | 0.0468 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 1 | 1748 | 230 | 0.2738 | 0.2879 | 0.1316 | 0.1549 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 2 | 1817 | 313 | 0.2712 | 0.2879 | 0.1723 | 0.1549 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 3 | 2106 | 339 | 0.3187 | 0.2879 | 0.1610 | 0.1549 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 8079 | 212 | 0.4118 | 0.4364 | 0.0262 | 0.0207 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 3 | 950 | 43 | 0.8907 | 0.8036 | 0.0453 | 0.0497 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 7818 | 140 | 0.4019 | 0.4364 | 0.0179 | 0.0207 |
WM-115 | Vemurafenib | Belinostat | 0.100 | 0.000 | uM | 72 | hr | 3 | 3136 | 146 | 0.8573 | 0.8519 | 0.0466 | 0.0498 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 20940 | 1098 | 1.0048 | 1.0000 | 0.0524 | 0.0504 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 0.000 | uM | 72 | hr | 1 | 1042 | 801 | 0.0435 | 0.0334 | 0.7687 | 0.8371 |
WM-115 | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 2072 | 591 | 0.3540 | 0.3601 | 0.2852 | 0.2576 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 0.000 | uM | 72 | hr | 3 | 1251 | 1101 | 0.0271 | 0.0334 | 0.8801 | 0.8371 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 0.000 | uM | 72 | hr | 2 | 1199 | 1034 | 0.0298 | 0.0334 | 0.8624 | 0.8371 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 1 | 1250 | 489 | 0.1372 | 0.1377 | 0.3912 | 0.4424 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 2 | 1366 | 641 | 0.1307 | 0.1377 | 0.4693 | 0.4424 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 3 | 1510 | 705 | 0.1452 | 0.1377 | 0.4669 | 0.4424 |
WM-115 | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 2066 | 489 | 0.3769 | 0.3601 | 0.2367 | 0.2576 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 1.000 | 0.000 | uM | 72 | hr | 3 | 900 | 279 | 0.6098 | 0.5178 | 0.3100 | 0.3105 |
WM-115 | Vemurafenib | Defactinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 2465 | 330 | 0.5103 | 0.5412 | 0.1339 | 0.1460 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 3.160 | 0.000 | uM | 72 | hr | 2 | 492 | 180 | 0.3064 | 0.3466 | 0.3659 | 0.3504 |
WM-115 | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 1950 | 489 | 0.3492 | 0.3601 | 0.2508 | 0.2576 |
WM-115 | Vemurafenib | Belinostat | 3.160 | 0.000 | uM | 72 | hr | 3 | 1968 | 434 | 0.4398 | 0.4271 | 0.2205 | 0.2254 |
WM-115 | Vemurafenib | Belinostat | 3.160 | 0.000 | uM | 72 | hr | 2 | 1953 | 461 | 0.4278 | 0.4271 | 0.2360 | 0.2254 |